Physician profile
Gem M Ashby
NPI 1811145865
$1,964.48
in general payments reported to CMS, 2019-2025
27 companies · $233 in 2025
The $233 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $453 · 2020: $80.13 · 2021: $127 · 2022: $109 · 2023: $161 · 2024: $802 · 2025: $233.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Honoraria: $600 · Food and Beverage: $596.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Honoraria | $600.00 |
| Food and Beverage | $595.72 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Fisher & Paykel Healthcare Limited | $600.00 | 2024 | Fisher & Paykel Healthcare |
| Hologic Sales and Service, LLC | $251.55 | 2019-2025 | Aptima, Thinprep 2000 Processor, Myosure Tissue Removal Device |
| Baxter Healthcare | $122.49 | 2019 | |
| Pfizer INC. | $118.22 | 2022-2024 | |
| Abbvie INC. | $112.13 | 2019-2023 | Liletta |
| Therapeuticsmd, INC. | $87.03 | 2019-2022 | |
| Exeltis, USA INC. | $79.31 | 2022-2025 | Slynd |
| Astellas Pharma US INC | $67.28 | 2023-2025 | Veozah |
| Ethicon US, LLC | $61.69 | 2019 | |
| Dysis Medical, INC. | $58.85 | 2019 | |
| Myovant Sciences INC. | $55.20 | 2021-2022 | |
| Mayne Pharma Commercial LLC | $34.41 | 2025 | |
| Smith+Nephew, INC. | $33.20 | 2024 | Pico 14 |
| Organon LLC | $33.05 | 2022-2025 | Nexplanon |
| Dexcom, INC. | $30.97 | 2025 | Dexcom G6 Transmitter |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sage Therapeutics, LLC | $25.21 | 2025 | Zurzuvae |
| Sumitomo Pharma America, INC. | $25.01 | 2023 | Myfembree |
| Bayer Healthcare Pharmaceuticals INC. | $23.37 | 2025 | |
| Coopersurgical, INC. | $21.12 | 2023 | Mara Console |
| Meditrina | $21.01 | 2024 | |
| Mimedx Group, INC. | $18.13 | 2024 | |
| Millicent US INC | $17.35 | 2025 | Femlyv |
| Merck Sharp & Dohme LLC | $16.53 | 2019 | |
| Avion Pharmaceuticals | $15.06 | 2020 | |
| Amag Pharmaceuticals, INC. | $12.67 | 2019 | |
| Lupin INC. | $12.10 | 2019 | |
| Allergan, INC. | $11.54 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gem Ashby listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.